Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
National
Mark Moore

FOUND: Ftc sues middlemen for inflating insulin drug prices | Mind Blowing Facts

Lina Khan, the head of the Federal Trade Commission, testifies before a House panel in May. The FTC on Friday sued three prescription drug gatekeepers, alleging they worked to artificially increase the price of insulin to boost their profits. (Credit: Kevin Dietsch/Getty Images)

The Federal Trade Commission on Friday sued three of the largest prescription drug middlemen, accusing the health companies of steering diabetes patients toward higher-priced insulin to increase their profits.

The three - CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express Scripts - are known as prescription drug benefit managers (PBMs).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.